WallStreetZenWallStreetZen

NASDAQ: LMRI
Lumexa Imaging Holdings Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for LMRI

Based on 3 analysts offering 12 month price targets for Lumexa Imaging Holdings Inc

Min Forecast
$22.00+79.59%
Avg Forecast
$22.67+85.04%
Max Forecast
$23.00+87.76%

Should I buy or sell LMRI stock?

Based on 3 analysts offering ratings for Lumexa Imaging Holdings Inc.

Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although LMRI's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates LMRI as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their LMRI stock forecasts and price targets.

LMRI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-01-05
lockedlocked$00.00+00.00%2026-01-05
lockedlocked$00.00+00.00%2026-01-05
lockedlocked$00.00+00.00%2026-01-05

1 of 1

Forecast return on equity

Is LMRI forecast to generate an efficient return?

Company
59.2%
Industry
20.9%
Market
356.86%
LMRI's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is LMRI forecast to generate an efficient return on assets?

Company
5.85%
Industry
11.67%
LMRI is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

LMRI earnings per share forecast

What is LMRI's earnings per share in the next 2 years based on estimates from 9 analysts?

Avg 1 year Forecast
$0.80
Avg 2 year Forecast
$1.05

LMRI revenue forecast

What is LMRI's revenue in the next 2 years based on estimates from 9 analysts?

Avg 1 year Forecast
$1.1B
Avg 2 year Forecast
$1.2B

LMRI vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
AIMD$2.00N/AN/A
AMIX$0.40N/AN/A
AORT$40.77$49.36+21.07%Buy
ALUR$1.35$2.50+85.19%Hold
ADGM$1.00$4.00+300.00%Strong Buy
View Top Medical Device Stocks

Lumexa Imaging Holdings Stock Forecast FAQ

Is Lumexa Imaging Holdings Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: LMRI) stock is to Strong Buy LMRI stock.

Out of 3 analysts, 2 (66.67%) are recommending LMRI as a Strong Buy, 1 (33.33%) are recommending LMRI as a Buy, 0 (0%) are recommending LMRI as a Hold, 0 (0%) are recommending LMRI as a Sell, and 0 (0%) are recommending LMRI as a Strong Sell.

If you're new to stock investing, here's how to buy Lumexa Imaging Holdings stock.

What is LMRI's earnings growth forecast for 2026-2027?

(NASDAQ: LMRI) Lumexa Imaging Holdings's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 41.78%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 3,205.53%.

Lumexa Imaging Holdings's earnings in 2026 is N/A.On average, 9 Wall Street analysts forecast LMRI's earnings for 2026 to be $75,728,174, with the lowest LMRI earnings forecast at $56,531,347, and the highest LMRI earnings forecast at $105,251,571.

In 2027, LMRI is forecast to generate $98,934,585 in earnings, with the lowest earnings forecast at $87,113,879 and the highest earnings forecast at $118,159,782.

What is LMRI's revenue growth forecast for 2026-2027?

(NASDAQ: LMRI) Lumexa Imaging Holdings's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 12.42%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,548.38%.

Lumexa Imaging Holdings's revenue in 2026 is N/A.On average, 9 Wall Street analysts forecast LMRI's revenue for 2026 to be $102,981,995,028, with the lowest LMRI revenue forecast at $98,442,843,732, and the highest LMRI revenue forecast at $107,899,408,932.

In 2027, LMRI is forecast to generate $108,845,065,452 in revenue, with the lowest revenue forecast at $103,833,085,896 and the highest revenue forecast at $114,519,004,572.

What is LMRI's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: LMRI) forecast ROA is 5.85%, which is lower than the forecast US Medical Devices industry average of 11.67%.

What is LMRI's Price Target?

According to 3 Wall Street analysts that have issued a 1 year LMRI price target, the average LMRI price target is $22.67, with the highest LMRI stock price forecast at $23.00 and the lowest LMRI stock price forecast at $22.00.

On average, Wall Street analysts predict that Lumexa Imaging Holdings's share price could reach $22.67 by Jan 5, 2027. The average Lumexa Imaging Holdings stock price prediction forecasts a potential upside of 85.04% from the current LMRI share price of $12.25.

What is LMRI's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: LMRI) Lumexa Imaging Holdings's current Earnings Per Share (EPS) is N/A. On average, analysts forecast that LMRI's EPS will be $0.80 for 2026, with the lowest EPS forecast at $0.60, and the highest EPS forecast at $1.11. In 2027, LMRI's EPS is forecast to hit $1.05 (min: $0.92, max: $1.25).

What is LMRI's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: LMRI) forecast ROE is 59.2%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.